Atropine: The Answer to Your Questions
Treehouse Eyes
Treehouse Eyes is a pediatric specialty eye care business focused on treating myopia (nearsightedness) in children.
We received a lot of questions about our recent issue that discussed using 0.01% atropine as a combination therapy.?Specifically, questions centered around two recent studies using 0.01% as monotherapy.?The questions came up because the two studies produced different results.?The CHAMP study supported using it and?this study?showed it was no better than a placebo.?These two opposing studies point toward the importance of the stability of compounded atropine.?The possibility exists that “what’s on the label, may not be what’s in the bottle,” especially over time.?At this point, our recommendation is to not start monotherapy with 0.01%.?Our experience has been that higher concentrations are well tolerated by most patients.
For our Los Angeles area readers, please note that Dr. Gary Gerber, Treehouse Eyes co-founder, will be speaking at the Los Angeles County Optometric Association on September 10th.?Drs. Melton and Thomas will also be at this event.?You can register?here.
Join us for our next webinar in the Treehouse Eyes National CE Series on August 29th featuring Dr. Thanh Mai of Treehouse Eyes. Dr. Vito Vricella of Fenton Family Eyecare, Dr. Dave Shin of Gig Harbor Eye Care, and Dr. Tina Tsai of The Eye Studio.?Register here.?
?Treehouse Eyes remains steadfast in our promise to give your patients, like the one pictured below, better vision for life. And we need your help to do that. So, the next time you see a myopic kid – and your next young patient is likely to be myopic, remember that?with your help,?we can work together?and provide life-changing treatments for your myopic patients.?For a Treehouse Eyes center near you,?click here.